Rockefeller Capital Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-101
| Closed | -$1K | – | 2492 |
|
|
2022
Q4 | $1K | Sell |
101
-56
| -36% | -$554 | ﹤0.01% | 3669 |
|
|
2022
Q3 | $3K | Sell |
157
-70
| -31% | -$1.34K | ﹤0.01% | 3474 |
|
|
2022
Q2 | $7K | Sell |
227
-16
| -7% | -$493 | ﹤0.01% | 3288 |
|
|
2022
Q1 | $9K | Buy |
+243
| New | +$9K | ﹤0.01% | 3099 |
|
|
2021
Q4 | – | Sell |
-200
| Closed | -$10K | – | 3821 |
|
|
2021
Q3 | $10K | Sell |
200
-12
| -6% | -$600 | ﹤0.01% | 2883 |
|
|
2021
Q2 | $13K | Buy |
212
+12
| +6% | +$736 | ﹤0.01% | 2661 |
|
|
2021
Q1 | $18K | Sell |
200
-600
| -75% | -$54K | ﹤0.01% | 2323 |
|
|
2020
Q4 | $71K | Sell |
800
-119
| -13% | -$10.6K | ﹤0.01% | 1565 |
|
|
2020
Q3 | $94K | Sell |
919
-44
| -5% | -$4.5K | ﹤0.01% | 1281 |
|
|
2020
Q2 | $76K | Buy |
963
+510
| +113% | +$40.2K | ﹤0.01% | 1269 |
|
|
2020
Q1 | $26K | Buy |
453
+240
| +113% | +$13.8K | ﹤0.01% | 1423 |
|
|
2019
Q4 | $11K | Hold |
213
| – | – | ﹤0.01% | 1576 |
|
|
2019
Q3 | $11K | Sell |
213
-14
| -6% | -$723 | ﹤0.01% | 1387 |
|
|
2019
Q2 | $11K | Sell |
227
-136
| -37% | -$6.59K | ﹤0.01% | 1198 |
|
|
2019
Q1 | $18K | Buy |
+363
| New | +$18K | ﹤0.01% | 1280 |
|